Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8258656 | Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2018 | 8 Pages |
Abstract
Moreover, we compared the relative mRNA transcript levels of CNBP gene in leukocytes and in skeletal muscle tissues from controls and DM2 patients. We found that CpG sites located in the promoter region showed hypomethylation, whereas CpG sites at 3â² end of the CCTG array are hypermethylated. Statistical analyses did not demonstrate any significant differences in the methylation profile between DM2 patients and controls in both tissues analyzed. According to the methylation analysis, CNBP gene expression levels are not significantly altered in DM2 patients. These results show that [CCTG]n repeat expansion, differently from the DM1 mutation, does not influence the methylation status of the CNBP gene and suggest that other molecular mechanisms are involved in the pathogenesis of DM2.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Massimo Santoro, Luana Fontana, Francesca Maiorca, Federica Centofanti, Roberto Massa, Gabriella Silvestri, Giuseppe Novelli, Annalisa Botta,